Drugs / S47445
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02805439 | Mar 2016 → Apr 2017 | major depressive disorder | Servier | Completed | No outcome recorded |
| Phase 2 | NCT02626572 | Feb 2015 → Sep 2017 | Alzheimer disease | Servier | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S47445 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02626572 ↗ |
| Route | Oral | “S47445 5 mg tablets taken orally once a day during breakfast” NCT02626572 ↗ |